Home » Corporate events » Archive by category "2013"

October 14 – 17, 2013

Alethia Biotherapeutics to be part of the World ADC San Francisco 2013.

Dr. Gilles Tremblay will be in attendance.

October 8 – 9, 2013

Alethia Biotherapeutics to be part of the 12th Annual BIO Investor Forum, the Palace Hotel, San Francisco, USA.

Yves Cornellier and Mario Filion will be in attendance.

October 4 – 7, 2013

Alethia Biotherapeutics to present at the Annual ASBMR Meeting at the Baltimore Convention Center, Baltimore, USA.  Drs. Julie Laurin and Gilles Tremblay will present data on a new generation of bone antiresoprtive:

Effects of AB-25E9, a Monoclonal Antibody Targeting Siglec-15, on Biomarkers of Bone Remodeling in Estrogen-Deficient Cynomolgus Monkeys . Poster presentation #SA0420, October   5

An Antibody Targeting Siglec-15 Decreases Bone Loss in OVX Rats by Reducing Osteoclast Acitivity and Increasing Bone Formation. Poster presentation #SU0260, October 6

October 2 – 3, 2013

Alethia Biotherapeutics to present at the BioContact conference on October 3 at 9:30 H, room Grande-Allée, Château Laurier, Quebec City, Canada.

Yves Cornellier and Gilles Tremblay will be in attendance.

June 14, 2013

Alethia Biotherapeutics is pleased to support its “Moon Walkers” team who is participating in this year’s Canadian Cancer Society Relay For Life, an overnight non-competitive relay that celebrates cancer survivors and pays tribute to loved ones.

May 31 – June 4, 2013

Alethia Biotherapeutics to be part of the ASCO 2013 Annual Meeting in Chicago, USA

Mario Filion and Gilles Tremblay will be in attendance.

April 22 – 25, 2013

Alethia Biotherapeutics to be part of the 2013 BIO International Convention in Chicago, USA.

Yves Cornellier and Mario Filion will be in attendance.

March 11-13, 2013

Alethia Biotherapeutics to be part of the BIO Europe Spring 2013 Annual International Partnering Conference in Barcelona, Spain.

Yves Cornellier and Mario Filion will be in attendance.